We then examined MET and PD-L1 levels in tumor tissue microarray from 140 PDAC patients (Fig. 3E) and found that approximately 68 % specimens with high MET expression levels exhibited intense PD-L1 staining, confirming the positive correlation between them in pancreatic cancer (Fig. 3F). The gene discussed is MET; the disease is neoplasm.